VERACYTE, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
VCYT$24.06-7.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
Consolidated Balance Sheets
(in thousands, except share and par value amounts)
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $362,578 | $239,087 |
| Short-term investments | 50,311 | 50,354 |
| Accounts receivable | 44,660 | 46,525 |
| Supplies and inventory | 20,546 | 21,750 |
| Prepaid expenses and other current assets | 10,281 | 14,551 |
| Total current assets | 488,376 | 372,267 |
| Property, plant and equipment, net | 22,192 | 22,953 |
| Right-of-use assets, operating leases | 36,599 | 48,189 |
| Intangible assets, net | 89,148 | 102,301 |
| Goodwill | 767,154 | 745,800 |
| Restricted cash | 1,648 | 1,544 |
| Other assets | 902 | 6,981 |
| Total assets | $1,406,019 | $1,300,035 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $4,593 | $8,634 |
| Accrued liabilities | 48,801 | 43,826 |
| Current portion of deferred revenue | 1,160 | 1,673 |
| Current portion of acquisition-related contingent consideration | 1,332 | 16,981 |
| Current portion of operating lease liabilities | 4,051 | 7,500 |
| Current portion of other liabilities | — | 19 |
| Total current liabilities | 59,937 | 78,633 |
| Deferred tax liability | 646 | 1,227 |
| Acquisition-related contingent consideration, net of current portion | 257 | 561 |
| Operating lease liabilities, net of current portion | 35,603 | 43,237 |
| Other liabilities | — | 411 |
| Total liabilities | 96,443 | 124,069 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized, 79,359,005 and 77,772,678 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 79 | 78 |
| Additional paid-in capital | 1,695,339 | 1,655,961 |
| Accumulated deficit | (377,630) | (443,983) |
| Accumulated other comprehensive loss | (8,212) | (36,090) |
| Total stockholders' equity | 1,309,576 | 1,175,966 |
| Total liabilities and stockholders' equity | $1,406,019 | $1,300,035 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.